Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-07-08 4:57 pm Purchase |
2022-06-30 | 13G | Cogent Biosciences, Inc. COGT |
BLACKROCK INC BLK |
3,296,780 3.800% |
598,126 (+22.16%) |
Filing History |
| 2022-06-21 10:04 am Purchase |
2022-06-16 | 13D | Cogent Biosciences, Inc. COGT |
Fairmount Funds Management LLC | 15,230,473 19.990% |
15,230,473 (New Position) |
Filing History |
| 2022-06-17 08:00 am Purchase |
2022-06-13 | 13G | Cogent Biosciences, Inc. COGT |
Flynn James E | 5,876,805 9.640% |
5,876,805 (New Position) |
Filing History |
| 2022-03-01 2:40 pm Purchase |
2022-02-24 | 13G | Cogent Biosciences, Inc. COGT |
Frazier Life Sciences Public Fund, L.P. | 2,188,004 11.000% |
2,188,004 (New Position) |
Filing History |
| 2022-02-14 4:14 pm Purchase |
2021-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Venrock Healthcare Capital Partners II, L.P. | 4,302,126 9.990% |
4,302,126 (New Position) |
Filing History |
| 2022-02-14 4:14 pm Sale |
2021-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Ridgeback Capital Investments L.P. | 0 0.000% |
-1,252,250 (Position Closed) |
Filing History |
| 2022-02-14 4:07 pm Purchase |
2021-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Commodore Capital LP | 2,281,315 5.700% |
139,976 (+6.54%) |
Filing History |
| 2022-02-14 2:05 pm Purchase |
2021-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Logos Global Management LP | 150,000 0.400% |
150,000 (New Position) |
Filing History |
| 2022-02-14 1:38 pm Purchase |
2021-12-31 | 13G | Cogent Biosciences, Inc. COGT |
BIOTECHNOLOGY VALUE FUND L P | 3,114,532 7.500% |
282 (+0.01%) |
Filing History |
| 2022-02-14 11:33 am Purchase |
2021-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Eventide Asset Management, LLC | 3,514,909 8.800% |
3,514,909 (New Position) |
Filing History |
| 2022-02-11 4:17 pm Sale |
2021-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Ally Bridge MedAlpha Master Fund L.P. | 1,501,591 3.800% |
-121,000 (-7.46%) |
Filing History |
| 2022-02-11 1:34 pm Purchase |
2021-12-31 | 13G | Cogent Biosciences, Inc. COGT |
JANUS HENDERSON GROUP PLC JHG |
2,515,254 6.300% |
2,515,254 (New Position) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Cogent Biosciences, Inc. COGT |
BLACKROCK INC BLK |
2,698,654 6.800% |
2,698,654 (New Position) |
Filing History |
| 2022-01-25 11:32 am Unchanged |
2021-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Atlas Venture Fund IX L.P. | 916,196 2.300% |
0 (Unchanged) |
Filing History |
| 2021-11-17 3:39 pm Purchase |
2021-11-05 | 13G | Cogent Biosciences, Inc. COGT |
TCG Crossover Management LLC | 2,716,042 6.800% |
706,054 (+35.13%) |
Filing History |
| 2021-11-03 5:31 pm Purchase |
2021-10-07 | 13G | Cogent Biosciences, Inc. COGT |
Commodore Capital LP | 2,141,339 5.400% |
2,141,339 (New Position) |
Filing History |
| 2021-07-08 1:50 pm Purchase |
2021-06-28 | 13G | Cogent Biosciences, Inc. COGT |
TCG Crossover Management LLC | 2,009,988 5.200% |
2,009,988 (New Position) |
Filing History |
| 2021-02-16 4:19 pm Purchase |
2020-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Ridgeback Capital Investments L.P. | 1,252,250 5.200% |
1,252,250 (New Position) |
Filing History |
| 2021-02-16 3:21 pm Purchase |
2020-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Logos Global Master Fund LP | 1,920,500 5.700% |
1,920,500 (New Position) |
Filing History |
| 2021-02-12 4:15 pm Purchase |
2020-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Ally Bridge MedAlpha Master Fund L.P. | 1,622,591 5.100% |
1,622,591 (New Position) |
Filing History |